Adherium (ASX:ADR) received firm commitments to raise AU$900,000 through the issuance of roughly 900,000 convertible notes, according to a Monday filing with the Australian bourse.
Investors will receive one attaching option for every two shares issued under the convertible notes.
Phillip Asset Management and Trudell Medical each committed AU$450,000. Trudell Medical is a company associated and controlled by Adherium director George Baran, per the filing.
The notes bear an interest of 10% per annum and will mature nine months from the date of issue.
Funds will be used to support the ongoing roll-out of Adherium's proprietary Hailie smart inhaler platform in the US, the filing stated.
Adherium's shares tumbled 13% to an all-time low in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.